Siblings 期刊論文 [100/101] Collection Statistics 近3年內發表的文件:2(8.33%) 含全文筆數:19(79.17%) 文件下載次數統計 下載大於0次:19(100.00%) 下載大於100次:19(100.00%) 檔案下載總次數:10460(16.32%) 最後更新時間: 2024-11-28 11:02 Top Upload Loading... Top Download Loading... Recent Submissions Potential roles of gut microbiome i... A prospective phase II study of biw... A phase 2 study of liposomal irinot... Atezolizumab plus bevacizumab for p... Interim overall survival analysis o... An open label, single-arm, two-stag... Prevalence and estimated trend in c... The association between lifestyle f... The treatment patterns of non-metas... Prediction of hepatitis B virus rea...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-24 of 24. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2022-07	Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors	Annals of Oncology. 2022 Jul;33(Suppl. 6):S484.
2022-02-01	A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
2021-07	Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load	Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S142.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2020-02	Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat	Cancer Research. 2020 Feb;80(4, Suppl.):Meeting Abstract GS1-04.
2019-05	An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14)	Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 4101.
2018-01	The association between lifestyle factors and oral potentially malignant disorders in Taiwan	Cancer Science. 2018 Jan;109(Suppl. 1):325.
2017-07-31	The treatment patterns of non-metastatic prostate cancer in an Asian country	International Journal of Urology. 2017 Jul 31;24(Suppl. S1):98.
2017-05	Prevalence and estimated trend in chemotherapy use near death from population-based studies on cancer patients: A systematic review and meta-analysis	Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 6590.
2017	Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification	Journal of Hepatology. 2017;66(1, Suppl.):S259.
2016-10-01	The prognostic impact of overall treatment time on disease outcomes of uterine cervical cancer patients: A nationwide cohort study of Taiwan	International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):E301.
2016-10-01	The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan	International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):S15-S16.
2016-10	The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study	Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
2015-12	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial	Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
2015-05	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
2015-04	Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection	Journal of Hepatology. 2015 Apr;62, Suppl. 2:S563.
2011-09	Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006	European Journal of Cancer. 2011 Sep;47(Suppl 1):S229-S230.
2009-09	Performance of medical oncologists on end-of-life care for Taiwanese cancer decedents, 2001-2006	EJC Supplements. 2009 Sep;7(2):179.
2009-09	Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors	EJC Supplements. 2009 Sep;7(3):16.
2007	A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients	Journal of Hepatology. 2007;46(Suppl. 1):S297.
2006-01	Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma	Head and Neck. 2006 Jan;28(1):74-80.
2005-05-20	Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma	Journal of Clinical Oncology. 2005 May;23(15):3568-3576.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.
1999-09	A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC)	European Journal of Cancer. 1999 Sep;35:S259.

Showing items 1-24 of 24. (1 Page(s) Totally) 1  View [10|25|50] records per page